CV Sciences, Inc.
CVSI
$0.03
$0.00051.70%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.61M | 3.88M | 3.87M | 3.95M | 4.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.61M | 3.88M | 3.87M | 3.95M | 4.00M |
| Cost of Revenue | 1.95M | 2.21M | 2.09M | 2.09M | 2.15M |
| Gross Profit | 1.66M | 1.68M | 1.78M | 1.86M | 1.85M |
| SG&A Expenses | 2.14M | 2.06M | 2.01M | 1.92M | 2.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -522.00K | -- | -- | -- | -- |
| Total Operating Expenses | 3.60M | 4.29M | 4.13M | 4.04M | 4.62M |
| Operating Income | 11.00K | -403.00K | -261.00K | -83.00K | -620.00K |
| Income Before Tax | -102.00K | -740.00K | -456.00K | -584.00K | -622.00K |
| Income Tax Expenses | 7.00K | -14.00K | -- | -- | 6.00K |
| Earnings from Continuing Operations | -109.00K | -726.00K | -456.00K | -584.00K | -628.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -109.00K | -726.00K | -456.00K | -584.00K | -628.00K |
| EBIT | 11.00K | -403.00K | -261.00K | -83.00K | -620.00K |
| EBITDA | 93.00K | -289.00K | -180.00K | -7.00K | -557.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 184.26M | 184.33M | 182.26M | 172.42M | 163.08M |
| Average Diluted Shares Outstanding | 184.26M | 184.33M | 182.26M | 172.42M | 163.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |